Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Lustigman

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Advances in Parasitology|July 15, 2010
Control of important helminthic infections vaccine development as part of the solutionRobert Bergquist, Sara Lustigman
Molecular and Biochemical Parasitology|January 28, 2017
Lessons from the genomes and transcriptomes of filarial nematodesAlexandra Grote, Sara Lustigman, Elodie Ghedin
Expert Opinion on Drug Discovery|March 16, 2013
Genomics and emerging drug discovery technologiesMatthew Berriman, Sara Lustigman, James P McCarter
International Journal for Parasitology|September 19, 2003
CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctionsSara Lustigman, Angus J MacDonald, David Abraham
Plos Neglected Tropical Diseases|September 3, 2010
The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with ageFidelis Cho-Ngwa, Jing Liu, Sara Lustigman
The Journal of Biological Chemistry|November 25, 2003
The Caenorhabditis elegans cathepsin Z-like cysteine protease, Ce-CPZ-1, has a multifunctional role during the worms' developmentSarwar Hashmi, Jun Zhang, Yelena Oksov, et al.
Plos Neglected Tropical Diseases|October 27, 2009
Helminth genomics: The implications for human healthPaul J Brindley, Makedonka Mitreva, Elodie Ghedin, et al.
Trends in Parasitology|February 21, 2002
Towards a recombinant antigen vaccine against Onchocerca volvulusSara Lustigman, Eric R James, Wilson Tawe, et al.
Vaccines|May 31, 2020
The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant FormulationParakkal Jovvian George, Wanbo Tai, Lanying Du, et al.
Blood|February 11, 2003
Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl)Cheryl-Ann Lobo, Marilis Rodriguez, Marion Reid, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Advances in Parasitology|July 15, 2010
Control of important helminthic infections vaccine development as part of the solutionRobert Bergquist, Sara Lustigman
Molecular and Biochemical Parasitology|January 28, 2017
Lessons from the genomes and transcriptomes of filarial nematodesAlexandra Grote, Sara Lustigman, Elodie Ghedin
Expert Opinion on Drug Discovery|March 16, 2013
Genomics and emerging drug discovery technologiesMatthew Berriman, Sara Lustigman, James P McCarter
International Journal for Parasitology|September 19, 2003
CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctionsSara Lustigman, Angus J MacDonald, David Abraham
Plos Neglected Tropical Diseases|September 3, 2010
The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with ageFidelis Cho-Ngwa, Jing Liu, Sara Lustigman
The Journal of Biological Chemistry|November 25, 2003
The Caenorhabditis elegans cathepsin Z-like cysteine protease, Ce-CPZ-1, has a multifunctional role during the worms' developmentSarwar Hashmi, Jun Zhang, Yelena Oksov, et al.
Plos Neglected Tropical Diseases|October 27, 2009
Helminth genomics: The implications for human healthPaul J Brindley, Makedonka Mitreva, Elodie Ghedin, et al.
Trends in Parasitology|February 21, 2002
Towards a recombinant antigen vaccine against Onchocerca volvulusSara Lustigman, Eric R James, Wilson Tawe, et al.
Vaccines|May 31, 2020
The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant FormulationParakkal Jovvian George, Wanbo Tai, Lanying Du, et al.
Blood|February 11, 2003
Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl)Cheryl-Ann Lobo, Marilis Rodriguez, Marion Reid, et al.
Pageof 14